The disclosure follows the high-profile failures of Pfizers lotiglipron and danuglipron, and comes on the heels of the Ph
Robert Popovian 04:00 So Conner, PBMs or pharmacy benefit management companies are multinational organizations that set up benefit design and negotiate on behalf of patients and employers with pharmaceutical industry to create coverage decisions for drugs
Originally developed for type 2 diabetes management, these medications have been authorised for weight management in individuals with obesity or those who are overweight with weight-related health conditions
Without enough protein, the body breaks down muscle alongside fat lowering metabolic rate and making long-term weight management harder
No Solid Evidence Yet for GLP-1 Agonists in Autoimmune Conditions First and foremost, its important to note that there is no strong scientific evidence right now that GLP-1 agonists, like semaglutide or tirzepatide, directly treat inflammatory arthritis or other autoimmune conditions